Revolutionizing disease treatment through chromatin reprogramming

At Focal Biosciences, we are building a platform and pipeline to reprogram cells to a healthier state and deliver disease modifying medicines against chronic diseases.

Transforming the Future of Medicine

The Power of Chromatin Fingerprints

Our core technology, the CFC (Chromatin Fingerprint for Cell state)-Platform, epitomizes a new approach to reprogramming cells, distinguished by speed, breadth, and an AI-enhanced approach to provide unique insights into complex biological processes. We believe that biology cannot be solved with limited datasets and narrow perspectives.

blob blob blob blob blob blob

A New Chapter for Drug Discovery

We're redefining drug discovery by searching for drugs that not only slow down disease progression but actually reprogram cells at the chromatin level to reverse disease.

Our approach is not only superior, but also can be used to investigate age-related diseases across a range of human tissues, thanks to our tissue-mimicking disease models and machine learning.

Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer
Aging
FIBROSIS
Senescence
Cancer

Our Focus: Today and Tomorrow

Our immediate focus lies in addressing fibrotic diseases, but our vision encompasses a broader range of age-related chronic diseases. We’re not just aiming to treat diseases; we’re striving to reverse and cure them.

Collaboration Opportunities

We invite industry leaders and innovators to collaborate with us in this transformative journey and be part of a groundbreaking shift in targeting diseases through reprogramming.

Join us

A team of experienced visionaries

Together, we will make a significant impact on drug discovery for patients globally, transforming the way we think about treating diseases.

OPERATIONS
Glenn Croston, PhD

Glenn Croston, PhD

Chief Operations Officer

Anne Shim Ullmer, PhD

Anne Shim Ullmer, PhD

Chief Data Officer

Nicholas Molnar

Nicholas Molnar

Head of Finance

BOARD OF DIRECTORS
Jan Adams, PhD

Jan Adams, PhD

Executive Chairman

Alexandra Bause

Alexandra Bause

Executive Partner

Prof. G.V Shivashankar, PhD

Prof. G.V Shivashankar, PhD

Scientific Co-Founder

SCIENTIFIC ADVISORS
Prof. Caroline Uhler, PhD

Prof. Caroline Uhler, PhD

Scientific Advisor

OPEN JOB
Another Visionary

Another Visionary

Find out more

For more information about partnering or investment inquiries, please get in touch.

Contact us